Atlas FDA

JUVEDERM VOLUMA XC

FDA premarket approval P110033/S021 · decided 2016-09-12

Approval details

PMA number
P110033
Supplement
S021
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
JUVEDERM VOLUMA XC
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2016-03-21
Decision date
2016-09-12
Days to decision
175 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
Approval for the labeling for Juvederm Voluma XC has been revised as follows: 1) to include the results of the completed post-approval study; 2) to include revisions to the postmarket surveillance summary; and 3) to include minor revisions intended to harmonize the directions with those of other Juvederm products.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25